1. Abrams, M. J., Juweid, M., TenKate, C. I., Schwartz, D. A., Hauser, M. M., Gaul, F. E., Fuccello, A. J., Rubin, R. H., Strauss, H. W., and Fischman, A. J., Technetium-99m-human polyclonal IgG radiolabeledvia the hydrazino nicotininamide derivative for imaging focal sites of infection in rats.J. Nucl. Med., 31, 2022–2028 (1990).
2. Babich, J. W. and Fischman, A. J., Effect of “co-ligand” on the biodistribution of99mTc-labeled hydrazino nicotinic acid derivatized chemotactic peptides.Nucl. Med. Biol., 22, 25–30 (1995).
3. Babich, J. W., Solomon, H., Pike, M. C., Kroon, D., Graham, W., Abrams, M. J., Tompkins, R. G., Rubin, R. H., and Fischman, A. J., Technetium-99m-labeled hydrazine nicotinamide derivatized chemotactic peptide analogues for imaging focal sites of bacterial infection.J. Nucl. Med., 34, 1964–1974 (1993).
4. Bradford, M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.Anal. Biochem., 72, 248–254 (1976).
5. Carrasquillo, J. A., Bunn, P. A., Keenan, A. M., Reynolds, J. C., Schroff, R. W., Foon, K. A., Su, M. H., Gazdar, A. F., Mulshine, J. L., and Oldham, R. K., Radioimmunodetection of cutaneous T-cell lymphoma with ln-111-labeled T101 monoclonal antibody.N. Engl. J. Med., 315, 673–680 (1986).